Walleye Trading
KRTX

Walleye Trading’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Walleye Trading’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,100
Closed -$348K – 5583
2023
Q4 		$348K Sell
1,100
-1,500
-58% -$292K ﹤0.01% 3387
2023
Q3 		$440K Sell
2,600
-2,700
-51% -$508K ﹤0.01% 3053
2023
Q2 		$1.15M Sell
5,300
-3,300
-38% -$707K ﹤0.01% 2052
2023
Q1 		$1.56M Sell
8,600
-8,700
-50% -$1.66M ﹤0.01% 1855
2022
Q4 		$3.4M Buy
17,300
+1,700
+11% +$365K 0.01% 1316
2022
Q3 		$3.51M Sell
15,600
-30,100
-66% -$6.09M 0.01% 1278
2022
Q2 		$5.78M Buy
45,700
+32,200
+239% +$3.7M 0.02% 930
2022
Q1 		$1.71M Buy
13,500
+10,900
+419% +$1.23M 0.01% 1780
2021
Q4 		$341K Buy
+2,600
New +$336K ﹤0.01% 3353
2021
Q2 		– Sell
-800
Closed -$96K – 5637
2021
Q1 		$96K Sell
800
-300
-27% -$34K ﹤0.01% 4117
2020
Q4 		$112K Buy
+1,100
New +$102K ﹤0.01% 3877
2020
Q3 		– Sell
-100
Closed -$11K – 4737
2020
Q2 		$11K Buy
+100
New +$8.69K ﹤0.01% 4066

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Walleye Trading's KRTX Position: Q1 2024 in Review

Walleye Trading sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,528 shares — an estimated $800K sold.

Walleye Trading first reported a position in KRTX in Q1 2022 and held it in 6 quarters. The position peaked at $1.29M in Q4 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Walleye Trading reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 2,528 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $800K.
  • Walleye Trading first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
  • Walleye Trading's Karuna Therapeutics, Inc. Common Stock position peaked at $1.29M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.